Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Meet Our Editorial Board Member:
Volume: 16 Issue: 2
Author(s): Heinz Wiendl
Affiliation:
Export Options
About this article
Cite this article as:
Wiendl Heinz, Meet Our Editorial Board Member:, Endocrine, Metabolic & Immune Disorders - Drug Targets 2016; 16 (2) . https://dx.doi.org/10.2174/187153031602160923151227
DOI https://dx.doi.org/10.2174/187153031602160923151227 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Functional, Genetic and Biochemical Biomarkers of Peripheral Arterial Disease
Current Medicinal Chemistry Rationally Designed Multitarget Agents Against Inflammation and Pain
Current Medicinal Chemistry Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design Pharmacokinetic Study and Trial for Preparation of Enteric-Coated Capsule Containing Insulinomimetic Vanadyl Compounds: Implications for Clinical Use
Mini-Reviews in Medicinal Chemistry Gender Dysphoria, Eating Disorders and Body Image: An Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Vitamin D Deficiency: The Invisible Accomplice of Metabolic Endotoxemia?
Current Pharmaceutical Design GPE and GPE Analogues as Promising Neuroprotective Agents
Mini-Reviews in Medicinal Chemistry Editorial (Hot Topic: Neurodegeneration: The First IBRO-Middle East Neuroscience Conference)
Current Alzheimer Research Genetic Insights into Sepsis: What have we Learned and How will it Help?
Current Pharmaceutical Design Changes in the Density of Corneal Endothelial Cells in Elderly Diabetic Patients After Combined Phacovitrectomy and Ex-PRESS Glaucoma Implants
Current Pharmaceutical Biotechnology Transforming Growth Factor Beta in Pancreatic Cancer
Current Pharmaceutical Biotechnology α 2-Adrenoceptor Antagonist SL84.0418 Involvement in the Development of Opioid Withdrawal
Letters in Drug Design & Discovery Nanotechnology and Treatment of Cardiovascular Disease: A Review of Nanoscale Innovations for Regenerative Therapy
Current Nanomedicine Solvent-Drop Grinding Method: Efficient Synthesis, DPPH Radical Scavenging and Anti-diabetic Activities of Chalcones, bis-chalcones, Azolines, and bis-azolines
Current Organic Synthesis Characterization of Peptide Polymer Interactions in Poly(alkylcyanoacrylate) Nanoparticles: A Mass Spectrometric Approach
Current Drug Delivery Hormonal Effects on Drug Metabolism Through the CYP System: Perspectives on Their Potential Significance in the Era of Pharmacogenomics
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Humanized Transgenic Mouse Models for Drug Metabolism and Pharmacokinetic Research
Current Drug Metabolism Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease
Current Drug Targets Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology Antimicrobial Agents-Associated with QT Interval Prolongation
Current Drug Safety